Legal & General Group PLC Forma Therapeutics Holdings, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $12,994 - $36,938	1,825 Added 17.91%	12,012 $240,000
Q2 2022 Aug 22, 2022	BUY	$5.1 - $10.0 $18,717 - $36,700	3,670 Added 56.31%	10,187 $70,000
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $68,455 - $82,908	3,226 Added 98.02%	6,517 $150,000
Q2 2021 Aug 12, 2021	SELL	$22.86 - $30.95 $12,275 - $16,620	-537 Reduced 14.03%	3,291 $82,000
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $30,430 - $53,011	1,238 Added 47.8%	3,828 $107,000
Q4 2020 Feb 12, 2021	BUY	$34.9 - $51.08 $27,256 - $39,893	781 Added 43.17%	2,590 $91,000
Q3 2020 Nov 13, 2020	BUY	$32.95 - $50.25 $59,606 - $90,902	1,809 New	1,809 $90,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.